Press Release Contact: Alan PetersonEmail:
American Healthcare REIT Announces Third Quarter 2026 Results; Increases Full Year 2026 Guidance American Healthcare REIT, Inc. (NYSE: AHR) (the “Company,” “we,” “our,” “us,” “management,” or "AHR") is announcing today its third quarter 2026 results and increasing full year 2026 guidance. Key Highlights (all figures reported for the three months ended September 30, 2026 and percentage changes are compared to the same period in 2025 unless otherwise noted) • GAAP net income attributable to controlling interest of $31.2 million, or $0.14 per diluted share. • Normalized Funds From Operations attributable to controlling interest (“NFFO”) of $0.58 per diluted share. • Achieved total portfolio Same- Store Net Operating Income (“Same-Store NOI”) growth of 13.8%. • Achieved Same- Store NOI growth of 28.2% and 15.7% in its senior housing operating properties (“SHOP”) and integrated senior health campuses (“ISHC”) segments, respectively. • Acquired approximately $1.69 billion of new investments within its SHOP segment. Since the beginning of 2026, the Company has completed approximately $2.07 billion in new investments. • Increased total portfolio Same-Store NOI growth guidance to 12.0% to 14.0% and NFFO per diluted share guidance to $2.23 to $2.26 for the year ending December 31, 2026. • Completed a follow-on common equity offering in August 2026, entering into forward sale agreements relating to 15,237,500 shares of common stock for approximately $819.0 million in gross proceeds. • Entered into forward sale agreements pursuant to its at-the-market equity offering program ("ATM Program"), to sell 14,385,140 shares of common stock for approximately $780.5 million in gross proceeds. Subsequent to quarter end, we entered into additional forward sale agreements pursuant to its ATM Program to sell 1,522,952 shares of common stock for approximately $77.1 million in gross proceeds, assuming full physical settlement. • As of November 5, 2026, pursuant to its ATM Program and its August 2026 follow-on common equity offering, the Company had unsettled forward sale agreements outstanding relating to 24,598,011 shares of common stock that would result in approximately $1.32 billion in gross proceeds assuming full physical settlement. • Reported a 0.6x improvement in Net Debt-to-Annualized Adjusted EBITDA to 1.9x as of September 30, 2026, from 2.5x as of June 30, 2026. • Strengthened the senior leadership team as Jeff Hanson was named Chief Executive Officer in addition to continuing to serve as Chairman, Gabe Willhite was elevated to President in addition to continuing to serve as Chief Operating Officer, and Scott Estes was appointed Lead Independent Director. The Company also added Aric Chang as Chief Financial Officer, Jon Crosier as Chief Technology Officer and Ann Lacey as Executive Vice President, Portfolio and Asset Management – Senior Housing. • Published 2025 Corporate Responsibility report committing to a 25% reduction in greenhouse gas Scope 1 and 2 emissions intensity by 2033 from a 2024 base year. • Recognized for workplace quality and corporate trust by Great Place To Work, Newsweek, U.S. News & World Report, and Fortune. “We strengthened three things this quarter: the team, the portfolio and the platform that connects them,” said Jeff Hanson, the Company’s Chairman and Chief Executive Officer. “We added executive leadership across finance, asset management, and technology, added nearly $2.1 billion of new investments in 2026, and brought new operating partners onto a platform that pairs their local expertise with portfolio-wide collaborations among the top operators in the senior housing industry. Importantly, this growth has been ambitious but disciplined. Superior care quality drives resident outcomes, and resident outcomes drive our performance. Our goal remains to be the preferred capital partner for the best senior housing operators in America, and we believe we made great strides in furtherance of that objective this quarter.” Page |1 Third Quarter 2026 Results The Company’s Same-Store NOI growth results for the three and nine months ended September 30, 2026 are detailed below. Same-Store NOI growth in the third quarter of 2026, compared to the same period in 2025, was led by the Company’s operating portfolio, comprised of its ISHC and SHOP segments, through strong pricing power driven by rate growth and effective expense control by its operating partners.
"Supply and demand dynamics alone do not guarantee success in this business," said Gabe Willhite, AHR's President and Chief Operating Officer. "Together with our roster of top regional operators, we executed on occupancy gains, dynamic pricing management and tight expense control to deliver 28.2% Same-Store NOI growth in SHOP and 15.7% in ISHC. We closed the third quarter with a solid foundation to enter the last quarter of 2026, which we believe should support growth entering 2027. The systems and standards we continue to support with our operating partners have propelled growth across our SHOP+ portfolio, which is comprised of our SHOP and ISHC segments." Transactional Activity During the three months ended September 30, 2026, the Company: • Acquired 17 new SHOP assets for approximately $1.69 billion, as previously announced. The properties are located in various states and will be managed and operated by new and existing regional operating partners. • Funded a loan for seven properties for approximately $86.2 million with purchase options to acquire the properties, as previously announced. The properties are currently operated by one of the Company's existing tenants who leases other buildings within its Triple-Net Leased Properties segment. Following the Company's completed transaction activity during the three months ended September 30, 2026, and subsequent to quarter end, the Company's investment pipeline consists of over $1.0 billion which includes newly awarded deals and deals in the pipeline previously disclosed in the Company's Second Quarter 2026 Earnings Release that have yet to close. While the Company expects to close the deals in its investment pipeline by the end of the first quarter in 2027, it cannot guarantee when or if these closings will take place. Therefore, the Company is not including any additional transaction activity, including the awarded deals in its investment pipeline, in its 2026 guidance, beyond the transactions disclosed as completed. Development Activity The Company's total in-process development and expansion pipeline is expected to cost approximately $192.9 million, of which $88.2 million had been funded as of September 30, 2026. Capital Markets and Balance Sheet Activity As of September 30, 2026, the Company had total consolidated indebtedness of $1.38 billion and approximately $2.35 billion of total liquidity, comprised of cash and cash equivalents, undrawn capacity on its lines of credit, and expected gross proceeds from unsettled forward sale agreements, assuming full physical settlement. The Company's Net-Debt-to-Annualized Adjusted EBITDA as of September 30, 2026, was 1.9x. Page |2 During the three months ended September 30, 2026, the Company entered into forward sale agreements pursuant to its ATM Program, to sell 14,385,140 shares of common stock for approximately $780.5 million in gross proceeds. Subsequent to quarter end, the Company entered into additional forward sale agreements pursuant to its ATM Program to sell 1,522,952 shares of common stock for approximately $77.1 million in gross proceeds, assuming full physical settlement. The Company also completed a follow-on common equity offering in August 2026, entering into new forward sale agreements to issue 15,237,500 shares of common stock for gross proceeds of approximately $819.0 million. During the three months ended September 30, 2026, the Company issued 36,833,346 shares of common stock to physically settle sales under forward sale agreements pursuant to its ATM Program and its May 2026 and August 2026 follow-on common equity offerings for gross proceeds of approximately $1.88 billion. Subsequent to quarter end, the Company issued an additional 589,179 shares of common stock to physically settle sales under forward sale agreements from its ATM Program and its August 2026 follow-on common equity offering for gross proceeds of approximately $31.2 million. As of November 5, 2026, pursuant to its ATM Program and its August 2026 follow-on common equity offering, the Company had unsettled forward sale agreements outstanding relating to 24,598,011 shares of common stock that would result in approximately $1.32 billion in gross proceeds assuming full physical settlement. “I am honored to join AHR at a pivotal moment for the Company and sector. AHR’s focus resonated with me: to serve a rapidly growing senior population by supporting top operators who deliver the best care,” said Aric Chang, the Company's Chief Financial Officer. “Our team and operating partners successfully executed on organic and external growth in the third quarter, which is why we are raising full-year guidance for Same-Store NOI growth and NFFO per diluted share. At the midpoint of revised guidance, we now expect 31% NFFO per diluted share growth over 2025, reflecting our continued focus on driving long-term shareholder value.” Full Year 2026 Guidance The Company is increasing NFFO per diluted share and Same-Store NOI growth guidance for the year ending December 31, 2026. The Company's 2026 guidance does not assume additional transaction or capital markets activity beyond the transactions or activity disclosed herein as completed. Guidance ranges are detailed below:
________________________________________ Certain of the assumptions underlying the Company’s 2026 guidance can be found within the Non-GAAP reconciliations in this earnings release and in the appendix of the Company’s Third Quarter 2026 Supplemental Financial Information (“Supplemental”). A reconciliation of net income (loss) calculated in accordance with generally accepted accounting principles in the United States ("GAAP") to NAREIT FFO and NFFO can be found within the Non-GAAP reconciliations in this earnings release. Non-GAAP financial measures and other terms, as used in this earnings release, are also defined and further explained in the Supplemental. The Company is unable to provide, without unreasonable effort, guidance for the most comparable GAAP financial measures of total revenues and property operating and maintenance expenses. Additionally, a reconciliation of the forward-looking non-GAAP financial measures of Same-Store NOI growth to the comparable GAAP financial measures cannot be provided without unreasonable effort because the Company is unable to reasonably predict certain items contained in the GAAP measures, including non-recurring and infrequent items that are not indicative of the Company’s ongoing operations. Such items include, but are not limited to, impairment on depreciated real estate assets, net gain or loss on sale of real estate assets, stock-based compensation, casualty loss, non-Same-Store revenue and non-Same-Store operating expenses. These items are uncertain, depend on various factors and could have a material impact on the Company’s GAAP results for the guidance period. Page |3
As previously announced, the Company’s Board of Directors declared a cash distribution for the quarter ended September 30, 2026 of $0.25 per share of its common stock. The third quarter distribution was paid in cash on October 16, 2026, to stockholders of record as of September 30, 2026.
The Company has disclosed supplemental information regarding its portfolio, financial position and results of operations as of, and for the three and nine months ended, September 30, 2026, and certain other information, which is available on the Investor Relations section of the Company's website athttps://ir.americanhealthcarereit.com.
The Company will host a webcast and conference call at 1:00 p.m. Eastern Time on November 6, 2026. During the conference call, Company executives will review third quarter 2026 results, discuss recent events and conduct a question-and- answer period.
To join via webcast, investors may use the following link:https://events.q4inc.com/attendee/980250267.
To join the live telephone conference call, please dial one of the following numbers at least five minutes prior to the start time:
North America Toll-Free: +1 833-461-5787 International Toll: +1 585-542-9983 International Dial-Ins:https://help.events.q4inc.com/eahc/international-dial-in- numbersMeeting ID: 980 250 267
A digital replay of the call will be available on the Investor Relations section of the Company’s website athttps://ir.americanhealthcarereit.comshortly after the conclusion of the call.
Certain statements contained in this press release, including statements relating to the Company's expectations regarding its performance and growth in 2027; full year 2026 guidance, including net income per diluted share, NAREIT FFO per diluted share, NFFO per diluted share, total portfolio Same-Store NOI growth, and segment-level Same-Store NOI growth and margin expansion; purchases and sales of assets, including the timing of the closing of deals in its investment pipeline; development plans; the settlement of forward sale agreements; emissions reduction targets and the benefits of additions to its management team, portfolio and platform may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends for all such forward-looking statements to be covered by the applicable safe harbor provisions for forward-looking statements contained in those acts. Such forward-looking statements generally can be identified by the use of forward-looking terminology, such as “may,” “will,” “can,” “expect,” “intend,” “anticipate,” “estimate,” “believe,” “continue,” “possible,” “initiatives,” “focus,” “seek,” “objective,” “goal,” “strategy,” “plan,” “potential,” “potentially,” “preparing,” “projected,” “future,” “long-term,” “once,” “should,” “could,” “would,” “might,” “uncertainty” or other similar words. Readers are cautioned not to place undue reliance on these forward- looking statements, which speak only as of the date of this press release. Any such forward-looking statements are based on current expectations, estimates and projections about the industry and markets in which the Company operates, and beliefs of, and assumptions made by, the Company's management and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied therein, including, without limitation, changing macroeconomic, domestic legal and fiscal policies; geopolitical conditions and other risks disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 27, 2026, and subsequent periodic reports filed with the Securities and Exchange Commission. Except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statements contained in this release.
The Company’s reported results are presented in accordance with GAAP. The Company also discloses the following non-GAAP financial measures: EBITDA, Adjusted EBITDA, Net Debt-to-Annualized Adjusted EBITDA, NAREIT FFO, NFFO, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI. The Company believes these non- GAAP financial measures are useful supplemental measures of its operating performance and are used by investors and analysts to compare the operating performance of the Company between periods and to other REITs or companies on a consistent basis without having to account for differences caused by unanticipated and/or incalculable items. Definitions of the non-GAAP financial measures used herein and reconciliations to the most directly comparable financial measure calculated in accordance with GAAP can be found at the end of this earnings release. See below and "Definitions" for further information regarding the Company's non-GAAP financial measures.
Management uses earnings before interest, taxes, depreciation and amortization (“EBITDA”) and Adjusted EBITDA to facilitate internal and external comparisons to our historical operating results and in making operating decisions. EBITDA and Adjusted EBITDA are widely used by investors, lenders, credit and equity analysts in the valuation, comparison, and investment recommendations of companies. Additionally, EBITDA and Adjusted EBITDA are utilized by our Board of Directors to evaluate management. Neither EBITDA nor Adjusted EBITDA represents net income (loss) or cash flows provided by operating activities as determined in accordance with GAAP and should not be considered as alternative measures of profitability or liquidity. In addition, management uses Net Debt-to-Annualized Adjusted EBITDA as a measure of our ability to service our debt. Finally, EBITDA and Adjusted EBITDA may not be comparable to similarly titled items reported by other REITs or other companies.
We believe that the use of FFO, which excludes the impact of real estate-related depreciation and amortization and impairments, provides a further understanding of our operating performance to investors, industry analysts and our management, and when compared year over year, reflects the impact on our operations from trends in Occupancy rates, rental rates, operating costs, general and administrative expenses and interest costs, which may not be immediately apparent from net income (loss) as determined in accordance with GAAP. However, FFO and NFFO should not be construed to be (i) more relevant or accurate than the current GAAP methodology in calculating net income (loss) as an indicator of our operating performance, (ii) more relevant or accurate than GAAP cash flows from operations as an indicator of our liquidity or (iii) indicative of funds available to fund our cash needs, including our ability to make distributions to our stockholders. The method utilized to evaluate the value and performance of real estate under GAAP should be construed as a more relevant measure of operational performance and considered more prominently than the non-GAAP FFO and NFFO measures and the adjustments to GAAP in calculating FFO and NFFO. Presentation of this information is intended to provide useful information to investors, industry analysts and management as they compare the operating performance metrics used by the REIT industry, although it should be noted that some REITs may use different methods of calculating funds from operations and normalized funds from operations, so comparisons with such REITs may not be meaningful.
We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are appropriate supplemental performance measures to reflect the performance of our operating assets because NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI exclude certain items that are not associated with the operations of the properties. We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are widely accepted measures of comparative operating performance in the real estate community and are useful to investors in understanding the profitability and operating performance of our property portfolio. However, our use of the terms NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts.
NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are not equivalent to our net income (loss) as determined under GAAP and may not be a useful measure of operational income or cash flows. Furthermore, NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be considered as alternatives to net income (loss) as an indication of our operating performance or as an alternative to cash flows from operations as an indication of our liquidity. NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI should not be construed to be more relevant or accurate than the GAAP methodology in calculating net income (loss). NOI, Cash NOI, Pro- Rata Cash NOI and Same-Store NOI should be reviewed in conjunction with other measurements as an indication of our performance.
American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, and in the United Kingdom and the Isle of Man.
Page |6 AMERICAN HEALTHCARE REIT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS As of September 30, 2026 and December 31, 2025 (In thousands, except share and per share amounts) (Unaudited)
September 30, December 31, 2026 2025 ────────────────────────────────────────────────────────────────────────────── ASSETS Real estate investments, net $ 5,949,084 $ 4,183,419 Debt investments, net 240,808 92,136 Cash and cash equivalents 222,767 114,836 Restricted cash 35,905 36,917 Accounts and other receivables, 228,503 204,313 net Identified intangible assets, 370,206 253,236 net Goodwill 234,942 234,942 Operating lease right-of-use 149,524 135,399 assets, net Other assets, net 177,618 171,028 Total assets $ 7,609,357 $ 5,426,226 LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND EQUITY Liabilities: Mortgage loans payable, net $ 814,957 $ 966,925 Lines of credit and term loan, 549,927 549,761 net Accounts payable and accrued 372,123 317,742 liabilities Identified intangible 1,717 2,110 liabilities, net Financing obligations 19,208 33,902 Operating lease liabilities 135,430 135,603 Security deposits, prepaid rent and 66,538 59,568 other liabilities Total liabilities 1,959,900 2,065,611 Commitments and contingencies Redeemable noncontrolling 66,810 — interests Equity: Stockholders’ equity: Preferred stock, $0.01 par value per share; 200,000,000 — — shares authorized; none issued and outstanding Common stock, $0.01 par value per share; 1,000,000,000 shares authorized; 231,479,253 and 185,911,442 2,311 1,852 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively Additional paid-in capital 7,164,243 4,880,169 Accumulated deficit (1,628,682 ) (1,559,279 ) Accumulated other comprehensive (2,205 ) (2,104 ) loss Total stockholders’ equity 5,535,667 3,320,638 Noncontrolling interests 46,980 39,977 Total equity 5,582,647 3,360,615 Total liabilities, redeemable noncontrolling interests and $ 7,609,357 $ 5,426,226 equity
Page |7 AMERICAN HEALTHCARE REIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME For the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands, except share and per share amounts) (Unaudited)
Page |8 AMERICAN HEALTHCARE REIT, INC. NAREIT FFO and Normalized FFO Reconciliation For the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands, except share and per share amounts) (Unaudited)
(1) For the three and nine months ended September 30, 2026, stock compensation expense includes $4,594,000 related to the accelerated vesting and modification of certain outstanding equity awards in connection with our previously disclosed Chief Executive Officer and Chief Financial Officer transitions during the third quarter of 2026, net of forfeitures. (2) Represents certain Ohio Medicaid quality incentive payments received by our ISHC segment pursuant to Ohio House Bill 479, or HB 479, that do not relate to the 2026 rate period. HB 479 was enacted in June 2026 and appropriated funding for nursing facility quality incentive payments. These amounts are included in resident fees and services revenue in our accompanying condensed consolidated statements of operations and comprehensive income, but are not reflective of our on-going operating performance. Page |9 AMERICAN HEALTHCARE REIT, INC. Adjusted EBITDA Reconciliation For the Three Months Ended September 30, 2026 (In thousands) (Unaudited)
Net income $ 31,515 Interest expense, net (including amortization of deferred financing costs and amortization of debt 17,773 discount/premium) Income tax expense 740 Depreciation and amortization (including amortization of leased assets and 91,403 accretion of lease liabilities) EBITDA 141,431 Income from unconsolidated entities (49 ) Straight line rent and amortization of (437 ) above/below market leases Non-cash impact of changes to equity 9,284 instruments Transaction, transition and 5,113 restructuring costs Amortization of direct origination and 739 closing costs — debt investments Foreign currency loss 619 Loss in fair value of derivative 106 financial instruments Other non-recurring income (8,815 ) Adjusted EBITDA $ 147,991
Page |10 AMERICAN HEALTHCARE REIT, INC. NOI and Cash NOI Reconciliation For the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands) (Unaudited)
(1) All periods are based upon current quarter's ownership percentage. Page |11 AMERICAN HEALTHCARE REIT, INC. Same-Store Revenue Reconciliation For the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands) (Unaudited)
(1) All periods are based upon current quarter's ownership percentage. (2) Relates to debt security investment and debt investment within Triple-Net Leased Properties. Page |13 AMERICAN HEALTHCARE REIT, INC. Same-Store NOI Reconciliation For the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands) (Unaudited)
Page |14 AMERICAN HEALTHCARE REIT, INC. Same-Store NOI Reconciliation - (Continued) For the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands) (Unaudited)
(1) All periods are based upon current quarter's ownership percentage. (2) Relates to debt security investment and debt investment within Triple-Net Leased Properties. Page |15 AMERICAN HEALTHCARE REIT, INC. Earnings Guidance Reconciliation For the Year Ending December 31, 2026 (Dollars and shares in millions, except per share amounts) (Unaudited)
Full Year Prior Full Year 2026 Guidance 2026 Guidance Low High Low High Net income attributable to $123.2 $129.2 $108.5 $116.5 common stockholders Depreciation and 322.1 322.1 306.8 306.8 amortization (1) Impairment and gains/losses from -3.5 -3.5 -3.9 -3.9 dispositions (1) NAREIT FFO attributable to $441.8 $447.8 $411.4 $419.4 common stockholders Amortization of other intangible 2.7 2.7 1.3 1.3 assets/liabilities (1) Change in deferred -1.3 -1.3 -1.6 -1.6 rent (1) Non-cash impact of changes to equity 26.3 26.3 21.9 21.9 plan (1) (2) Other adjustments -6.2 -6.2 -0.2 -0.2 (1) (3) Normalized FFO attributable to $463.3 $469.3 $432.8 $440.8 common stockholders Net income per common share — $0.59 $0.62 $0.54 $0.58 diluted NAREIT FFO per common share — $2.13 $2.16 $2.04 $2.08 diluted Normalized FFO per common share — $2.23 $2.26 $2.15 $2.19 diluted NAREIT FFO and Normalized FFO 207.7 207.7 201.3 201.3 weighted average shares — diluted Total Portfolio Same-Store NOI 12.0% 14.0% 11.0% 13.0% growth Segment-Level Same-Store NOI growth: ISHC 14.5% 16.5% 13.0% 16.0% SHOP 23.0% 26.0% 18.0% 21.0% Outpatient Medical 0.5% 1.0% 0.0% 1.0% Triple-Net Leased 2.5% 3.5% 2.0% 3.0% Properties
(1) Amounts presented net of noncontrolling interests' share and AHR's share of unconsolidated entities. (2) Amounts represent amortization of equity compensation and fair value adjustments to performance-based equity compensation. (3) Includes adjustments for capitalized interest, transaction, transition and restructuring costs, and additional items as noted in the Company’s definition of Normalized FFO. Page |16
Adjusted EBITDA: EBITDA excluding the impact of income or loss from unconsolidated entities, straight line rent and amortization of above/below market leases, non-cash impact of changes to equity instruments, transaction, transition and restructuring costs, gain or loss on dispositions of real estate investments, amortization of direct origination and closing costs on debt investments, unrealized foreign currency gain or loss, change in fair value of derivative financial instruments, impairments of real estate investments, impairments of intangible assets and goodwill, and non-recurring and/or one-time items.
Annualized Adjusted EBITDA: Current period (shown as quarterly) Adjusted EBITDA multiplied by 4.
Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items such as straight-line rent and the amortization of lease intangibles, (2) third- party facility rent payments and (3) other items set forth in the Cash NOI reconciliation included herein. Both Cash NOI and Same-Store NOI include Pro- Rata ownership and other adjustments.
EBITDA: A non-GAAP financial measure that is defined as earnings before interest, taxes, depreciation and amortization.
GAAP Revenue: Revenue recognized in accordance with Generally Accepted Accounting Principles (“GAAP”), which includes straight line rent and other non- cash adjustments.
ISHC: Integrated senior health campuses include a range of senior care, including independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. Integrated senior health campuses are operated utilizing a RIDEA structure.
NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a non-GAAP financial measure, consistent with the standards established by the White Paper on FFO approved by the Board of Governors of NAREIT (the “White Paper”). The White Paper defines FFO as net income (loss) computed in accordance with GAAP, excluding gains or losses from dispositions of certain real estate assets, gains or losses upon consolidation of a previously held equity interest, and impairment write-downs of certain real estate assets and investments, plus depreciation and amortization related to real estate, after adjustments for unconsolidated partnerships and joint ventures. While impairment charges are excluded from the calculation of FFO as described above, investors are cautioned that impairments are based on estimated future undiscounted cash flows. Adjustments for unconsolidated partnerships and joint ventures are calculated to reflect FFO.
Net Debt: Total Debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash related to debt. For a reconciliation of Net Debt to total debt, refer to the Company’s Third Quarter 2026 Supplemental Financial Information.
NOI: Net operating income; a non-GAAP financial measure that is defined as net income (loss), computed in accordance with GAAP, generated from properties before general and administrative expenses, transaction, transition and restructuring costs, depreciation and amortization, interest expense, gain or loss in fair value of derivative financial instruments, gain or loss on dispositions of real estate investments, impairment of real estate investments, impairment of intangible assets and goodwill, income or loss from unconsolidated entities, gain on re-measurement of previously held equity interest, foreign currency gain or loss, other income or expense and income tax benefit or expense.
Non-Core Properties: Assets that have been deemed not essential to generating future economic benefit or value to our day-to-day operations and/or are projected to be sold.
Normalized FFO or NFFO: FFO further adjusted for the following items included in the determination of GAAP net income (loss): transaction, transition and restructuring costs; amounts relating to changes in deferred rent and amortization of above- and below-market leases (which are adjusted in order to reflect such payments from a GAAP accrual basis); the non-cash impact of changes to our equity instruments; non-cash or non-recurring income or expense; the non- cash effect of income tax benefits or expenses; capitalized interest; impairment of intangible assets and goodwill; amortization of direct origination and closing costs on debt investments; mark-to-market adjustments included in net income (loss); gains or losses included in net income (loss) from the extinguishment or sale of debt, hedges, foreign exchange, derivatives or securities holdings where trading of such holdings is not a fundamental attribute of the business plan; and after adjustments for consolidated and unconsolidated partnerships and joint ventures, with such adjustments calculated to reflect Normalized FFO on the same basis.
Occupancy: With respect to OM, the percentage of total rentable square feet leased and occupied, including month-to-month leases, as of the date reported. With respect to all other property types, occupancy represents average quarterly operating occupancy based on the most recent quarter of available data. The Company uses unaudited, periodic financial information provided solely by tenants to calculate occupancy and has not independently verified the information.
Pro-Rata: As of September 30, 2026, we owned and/or operated buildings/properties through entities of which we owned less than 100% of the ownership interests. Because we have a controlling interest in these entities, these entities and the properties these entities own are consolidated in our financial statements in accordance with GAAP. However, while such properties are presented in our financial statements on a consolidated basis, we are only entitled to our Pro-Rata share of the net cash flows generated by such properties. As a result, we have presented certain property information herein based on our Pro-Rata ownership interest in these entities and the properties these entities own, as of the applicable date, and not on a consolidated basis. In such instances, information is noted as being presented on a “Pro-Rata share” basis.
RIDEA structure: A structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, pursuant to which we lease certain healthcare real estate properties to a wholly-owned taxable REIT subsidiary (“TRS”), which in turn contracts with an eligible independent contractor (“EIK”) to operate such properties for a fee. Under this structure, the EIK receives management fees, and the TRS receives revenue from the operation of the healthcare real estate properties and retains, as profit, any revenue remaining after payment of expenses (including intercompany rent paid to us and any taxes at the TRS level) necessary to operate the property. Through the RIDEA structure, in addition to receiving rental revenue from the TRS, we retain any after-tax profit from the operation of the healthcare real estate properties and benefit from any improved operational performance while bearing the risk of any decline in operating performance at the properties.
Same-Store or SS: Properties owned or consolidated the full year in both comparison years and that are not otherwise excluded. Properties are excluded from Same-Store if they are: (1) sold, classified as held for sale or properties whose operations were classified as discontinued operations in accordance with GAAP; (2) impacted by materially disruptive events, such as flood or fire for an extensive period of time; or (3) scheduled to undergo or currently undergoing major expansions/renovations or business model transitions or have transitioned business models after the start of the prior comparison period.
Same-Store NOI or SS NOI: Cash NOI for our Same-Store properties. Same-Store NOI is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. Both Cash NOI and Same-Store NOI include ownership and other adjustments.
Total Debt: The principal balances of the Company’s revolving credit facilities, term loan and secured indebtedness as reported in the Company’s consolidated financial statements.
Trilogy: Trilogy Investors, LLC; one of our consolidated subsidiaries, in which we indirectly own a 100% interest as of September 30, 2026.
Trilogy Management Services: Trilogy Management Services, LLC, an independent third-party operator that qualifies as an eligible independent contractor and manages all of the Company's integrated senior health campuses.
Triple-Net Leased: A lease where the tenant is responsible for making rent payments, maintaining the leased property, and paying property taxes and other expenses.
Full text with the tables
Exhibit 99.1
r
Press Release Contact: Alan PetersonEmail:
Irvine, CA – November 5, 2026 [email protected]
──────────────────────────────────────────────────────────────────────────────
American Healthcare REIT Announces Third Quarter 2026 Results; Increases Full
Year 2026 Guidance American Healthcare REIT, Inc. (NYSE: AHR) (the “Company,”
“we,” “our,” “us,” “management,” or "AHR") is announcing today its third quarter
2026 results and increasing full year 2026 guidance. Key Highlights (all figures
reported for the three months ended September 30, 2026 and percentage changes
are compared to the same period in 2025 unless otherwise noted) • GAAP net
income attributable to controlling interest of $31.2 million, or $0.14 per
diluted share. • Normalized Funds From Operations attributable to controlling
interest (“NFFO”) of $0.58 per diluted share. • Achieved total portfolio Same-
Store Net Operating Income (“Same-Store NOI”) growth of 13.8%. • Achieved Same-
Store NOI growth of 28.2% and 15.7% in its senior housing operating properties
(“SHOP”) and integrated senior health campuses (“ISHC”) segments, respectively.
• Acquired approximately $1.69 billion of new investments within its SHOP
segment. Since the beginning of 2026, the Company has completed approximately
$2.07 billion in new investments. • Increased total portfolio Same-Store NOI
growth guidance to 12.0% to 14.0% and NFFO per diluted share guidance to $2.23
to $2.26 for the year ending December 31, 2026. • Completed a follow-on common
equity offering in August 2026, entering into forward sale agreements relating
to 15,237,500 shares of common stock for approximately $819.0 million in gross
proceeds. • Entered into forward sale agreements pursuant to its at-the-market
equity offering program ("ATM Program"), to sell 14,385,140 shares of common
stock for approximately $780.5 million in gross proceeds. Subsequent to quarter
end, we entered into additional forward sale agreements pursuant to its ATM
Program to sell 1,522,952 shares of common stock for approximately $77.1 million
in gross proceeds, assuming full physical settlement. • As of November 5, 2026,
pursuant to its ATM Program and its August 2026 follow-on common equity
offering, the Company had unsettled forward sale agreements outstanding relating
to 24,598,011 shares of common stock that would result in approximately $1.32
billion in gross proceeds assuming full physical settlement. • Reported a 0.6x
improvement in Net Debt-to-Annualized Adjusted EBITDA to 1.9x as of September
30, 2026, from 2.5x as of June 30, 2026. • Strengthened the senior leadership
team as Jeff Hanson was named Chief Executive Officer in addition to continuing
to serve as Chairman, Gabe Willhite was elevated to President in addition to
continuing to serve as Chief Operating Officer, and Scott Estes was appointed
Lead Independent Director. The Company also added Aric Chang as Chief Financial
Officer, Jon Crosier as Chief Technology Officer and Ann Lacey as Executive Vice
President, Portfolio and Asset Management – Senior Housing. • Published 2025
Corporate Responsibility report committing to a 25% reduction in greenhouse gas
Scope 1 and 2 emissions intensity by 2033 from a 2024 base year. • Recognized
for workplace quality and corporate trust by Great Place To Work, Newsweek, U.S.
News & World Report, and Fortune. “We strengthened three things this quarter:
the team, the portfolio and the platform that connects them,” said Jeff Hanson,
the Company’s Chairman and Chief Executive Officer. “We added executive
leadership across finance, asset management, and technology, added nearly $2.1
billion of new investments in 2026, and brought new operating partners onto a
platform that pairs their local expertise with portfolio-wide collaborations
among the top operators in the senior housing industry. Importantly, this growth
has been ambitious but disciplined. Superior care quality drives resident
outcomes, and resident outcomes drive our performance. Our goal remains to be
the preferred capital partner for the best senior housing operators in America,
and we believe we made great strides in furtherance of that objective this
quarter.”
Page |1
Third Quarter 2026 Results The Company’s Same-Store NOI growth results for the
three and nine months ended September 30, 2026 are detailed below. Same-Store
NOI growth in the third quarter of 2026, compared to the same period in 2025,
was led by the Company’s operating portfolio, comprised of its ISHC and SHOP
segments, through strong pricing power driven by rate growth and effective
expense control by its operating partners.
Three Months Ended September 30, 2026
Relative to
Three Months Ended September 30, 2025
──────────────────────────────────────────────────────────────────────────────
Segment Same-Store NOI Growth
ISHC 15.7 %
SHOP 28.2 %
Outpatient Medical 0.4 %
Triple-Net Leased Properties 2.7 %
Total Portfolio 13.8 %
Nine Months Ended September 30, 2026
Relative to
Nine Months Ended September 30, 2025
──────────────────────────────────────────────────────────────────────────────
Segment Same-Store NOI Growth
ISHC 15.5 %
SHOP 22.9 %
Outpatient Medical 1.2 %
Triple-Net Leased Properties 3.1 %
Total Portfolio 13.1 %
"Supply and demand dynamics alone do not guarantee success in this business,"
said Gabe Willhite, AHR's President and Chief Operating Officer. "Together with
our roster of top regional operators, we executed on occupancy gains, dynamic
pricing management and tight expense control to deliver 28.2% Same-Store NOI
growth in SHOP and 15.7% in ISHC. We closed the third quarter with a solid
foundation to enter the last quarter of 2026, which we believe should support
growth entering 2027. The systems and standards we continue to support with our
operating partners have propelled growth across our SHOP+ portfolio, which is
comprised of our SHOP and ISHC segments." Transactional Activity During the
three months ended September 30, 2026, the Company: • Acquired 17 new SHOP
assets for approximately $1.69 billion, as previously announced. The properties
are located in various states and will be managed and operated by new and
existing regional operating partners. • Funded a loan for seven properties for
approximately $86.2 million with purchase options to acquire the properties, as
previously announced. The properties are currently operated by one of the
Company's existing tenants who leases other buildings within its Triple-Net
Leased Properties segment. Following the Company's completed transaction
activity during the three months ended September 30, 2026, and subsequent to
quarter end, the Company's investment pipeline consists of over $1.0 billion
which includes newly awarded deals and deals in the pipeline previously
disclosed in the Company's Second Quarter 2026 Earnings Release that have yet to
close. While the Company expects to close the deals in its investment pipeline
by the end of the first quarter in 2027, it cannot guarantee when or if these
closings will take place. Therefore, the Company is not including any additional
transaction activity, including the awarded deals in its investment pipeline, in
its 2026 guidance, beyond the transactions disclosed as completed. Development
Activity The Company's total in-process development and expansion pipeline is
expected to cost approximately $192.9 million, of which $88.2 million had been
funded as of September 30, 2026. Capital Markets and Balance Sheet Activity As
of September 30, 2026, the Company had total consolidated indebtedness of $1.38
billion and approximately $2.35 billion of total liquidity, comprised of cash
and cash equivalents, undrawn capacity on its lines of credit, and expected
gross proceeds from unsettled forward sale agreements, assuming full physical
settlement. The Company's Net-Debt-to-Annualized Adjusted EBITDA as of September
30, 2026, was 1.9x.
Page |2
During the three months ended September 30, 2026, the Company entered into
forward sale agreements pursuant to its ATM Program, to sell 14,385,140 shares
of common stock for approximately $780.5 million in gross proceeds. Subsequent
to quarter end, the Company entered into additional forward sale agreements
pursuant to its ATM Program to sell 1,522,952 shares of common stock for
approximately $77.1 million in gross proceeds, assuming full physical
settlement. The Company also completed a follow-on common equity offering in
August 2026, entering into new forward sale agreements to issue 15,237,500
shares of common stock for gross proceeds of approximately $819.0 million.
During the three months ended September 30, 2026, the Company issued 36,833,346
shares of common stock to physically settle sales under forward sale agreements
pursuant to its ATM Program and its May 2026 and August 2026 follow-on common
equity offerings for gross proceeds of approximately $1.88 billion. Subsequent
to quarter end, the Company issued an additional 589,179 shares of common stock
to physically settle sales under forward sale agreements from its ATM Program
and its August 2026 follow-on common equity offering for gross proceeds of
approximately $31.2 million. As of November 5, 2026, pursuant to its ATM Program
and its August 2026 follow-on common equity offering, the Company had unsettled
forward sale agreements outstanding relating to 24,598,011 shares of common
stock that would result in approximately $1.32 billion in gross proceeds
assuming full physical settlement. “I am honored to join AHR at a pivotal moment
for the Company and sector. AHR’s focus resonated with me: to serve a rapidly
growing senior population by supporting top operators who deliver the best
care,” said Aric Chang, the Company's Chief Financial Officer. “Our team and
operating partners successfully executed on organic and external growth in the
third quarter, which is why we are raising full-year guidance for Same-Store NOI
growth and NFFO per diluted share. At the midpoint of revised guidance, we now
expect 31% NFFO per diluted share growth over 2025, reflecting our continued
focus on driving long-term shareholder value.” Full Year 2026 Guidance The
Company is increasing NFFO per diluted share and Same-Store NOI growth guidance
for the year ending December 31, 2026. The Company's 2026 guidance does not
assume additional transaction or capital markets activity beyond the
transactions or activity disclosed herein as completed. Guidance ranges are
detailed below:
Full Year 2026
Guidance
Metric Midpoint Current FY 2026 Prior FY 2026
Range Range
Net income per $0.605 $0.59 to $0.62 $0.54 to $0.58
diluted share
NAREIT FFO per $2.145 $2.13 to $2.16 $2.04 to $2.08
diluted share
NFFO per diluted $2.245 $2.23 to $2.26 $2.15 to $2.19
share
Total Portfolio 13.0% 12.0% to 14.0% 11.0% to 13.0%
SS NOI Growth
Segment-Level SS
NOI Growth:
ISHC 15.5% 14.5% to 16.5% 13.0% to 16.0%
SHOP 24.5% 23.0% to 26.0% 18.0% to 21.0%
Outpatient 0.75% 0.5% to 1.0% 0.0% to 1.0%
Medical
Triple-Net Leased 3.0% 2.5% to 3.5% 2.0% to 3.0%
Properties
________________________________________ Certain of the assumptions underlying
the Company’s 2026 guidance can be found within the Non-GAAP reconciliations in
this earnings release and in the appendix of the Company’s Third Quarter 2026
Supplemental Financial Information (“Supplemental”). A reconciliation of net
income (loss) calculated in accordance with generally accepted accounting
principles in the United States ("GAAP") to NAREIT FFO and NFFO can be found
within the Non-GAAP reconciliations in this earnings release. Non-GAAP financial
measures and other terms, as used in this earnings release, are also defined and
further explained in the Supplemental. The Company is unable to provide, without
unreasonable effort, guidance for the most comparable GAAP financial measures of
total revenues and property operating and maintenance expenses. Additionally, a
reconciliation of the forward-looking non-GAAP financial measures of Same-Store
NOI growth to the comparable GAAP financial measures cannot be provided without
unreasonable effort because the Company is unable to reasonably predict certain
items contained in the GAAP measures, including non-recurring and infrequent
items that are not indicative of the Company’s ongoing operations. Such items
include, but are not limited to, impairment on depreciated real estate assets,
net gain or loss on sale of real estate assets, stock-based compensation,
casualty loss, non-Same-Store revenue and non-Same-Store operating expenses.
These items are uncertain, depend on various factors and could have a material
impact on the Company’s GAAP results for the guidance period.
Page |3
Distributions
As previously announced, the Company’s Board of Directors declared a cash
distribution for the quarter ended September 30, 2026 of $0.25 per share of its
common stock. The third quarter distribution was paid in cash on October 16,
2026, to stockholders of record as of September 30, 2026.
Supplemental Information
The Company has disclosed supplemental information regarding its portfolio,
financial position and results of operations as of, and for the three and nine
months ended, September 30, 2026, and certain other information, which is
available on the Investor Relations section of the Company's website
athttps://ir.americanhealthcarereit.com.
Conference Call and Webcast Information
The Company will host a webcast and conference call at 1:00 p.m. Eastern Time on
November 6, 2026. During the conference call, Company executives will review
third quarter 2026 results, discuss recent events and conduct a question-and-
answer period.
To join via webcast, investors may use the following
link:https://events.q4inc.com/attendee/980250267.
To join the live telephone conference call, please dial one of the following
numbers at least five minutes prior to the start time:
North America Toll-Free: +1 833-461-5787
International Toll: +1 585-542-9983
International Dial-Ins:https://help.events.q4inc.com/eahc/international-dial-in-
numbersMeeting ID: 980 250 267
A digital replay of the call will be available on the Investor Relations section
of the Company’s website athttps://ir.americanhealthcarereit.comshortly after
the conclusion of the call.
Forward-Looking Statements
Certain statements contained in this press release, including statements
relating to the Company's expectations regarding its performance and growth in
2027; full year 2026 guidance, including net income per diluted share, NAREIT
FFO per diluted share, NFFO per diluted share, total portfolio Same-Store NOI
growth, and segment-level Same-Store NOI growth and margin expansion; purchases
and sales of assets, including the timing of the closing of deals in its
investment pipeline; development plans; the settlement of forward sale
agreements; emissions reduction targets and the benefits of additions to its
management team, portfolio and platform may be considered forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The
Company intends for all such forward-looking statements to be covered by the
applicable safe harbor provisions for forward-looking statements contained in
those acts. Such forward-looking statements generally can be identified by the
use of forward-looking terminology, such as “may,” “will,” “can,” “expect,”
“intend,” “anticipate,” “estimate,” “believe,” “continue,” “possible,”
“initiatives,” “focus,” “seek,” “objective,” “goal,” “strategy,” “plan,”
“potential,” “potentially,” “preparing,” “projected,” “future,” “long-term,”
“once,” “should,” “could,” “would,” “might,” “uncertainty” or other similar
words. Readers are cautioned not to place undue reliance on these forward-
looking statements, which speak only as of the date of this press release. Any
such forward-looking statements are based on current expectations, estimates and
projections about the industry and markets in which the Company operates, and
beliefs of, and assumptions made by, the Company's management and involve known
and unknown risks and uncertainties that could cause actual results to differ
materially from those expressed or implied therein, including, without
limitation, changing macroeconomic, domestic legal and fiscal policies;
geopolitical conditions and other risks disclosed in the Company's Annual Report
on Form 10-K for the year ended December 31, 2025, filed on February 27, 2026,
and subsequent periodic reports filed with the Securities and Exchange
Commission. Except as required by law, the Company does not undertake any
obligation to update or revise any forward-looking statements contained in this
release.
Page |4
Non-GAAP Financial Measures
The Company’s reported results are presented in accordance with GAAP. The
Company also discloses the following non-GAAP financial measures: EBITDA,
Adjusted EBITDA, Net Debt-to-Annualized Adjusted EBITDA, NAREIT FFO, NFFO, NOI,
Cash NOI, Pro-Rata Cash NOI and Same-Store NOI. The Company believes these non-
GAAP financial measures are useful supplemental measures of its operating
performance and are used by investors and analysts to compare the operating
performance of the Company between periods and to other REITs or companies on a
consistent basis without having to account for differences caused by
unanticipated and/or incalculable items. Definitions of the non-GAAP financial
measures used herein and reconciliations to the most directly comparable
financial measure calculated in accordance with GAAP can be found at the end of
this earnings release. See below and "Definitions" for further information
regarding the Company's non-GAAP financial measures.
EBITDA and Adjusted EBITDA
Management uses earnings before interest, taxes, depreciation and amortization
(“EBITDA”) and Adjusted EBITDA to facilitate internal and external comparisons
to our historical operating results and in making operating decisions. EBITDA
and Adjusted EBITDA are widely used by investors, lenders, credit and equity
analysts in the valuation, comparison, and investment recommendations of
companies. Additionally, EBITDA and Adjusted EBITDA are utilized by our Board of
Directors to evaluate management. Neither EBITDA nor Adjusted EBITDA represents
net income (loss) or cash flows provided by operating activities as determined
in accordance with GAAP and should not be considered as alternative measures of
profitability or liquidity. In addition, management uses Net Debt-to-Annualized
Adjusted EBITDA as a measure of our ability to service our debt. Finally, EBITDA
and Adjusted EBITDA may not be comparable to similarly titled items reported by
other REITs or other companies.
NAREIT Funds from Operations (FFO) and Normalized Funds from Operations (NFFO)
We believe that the use of FFO, which excludes the impact of real estate-related
depreciation and amortization and impairments, provides a further understanding
of our operating performance to investors, industry analysts and our management,
and when compared year over year, reflects the impact on our operations from
trends in Occupancy rates, rental rates, operating costs, general and
administrative expenses and interest costs, which may not be immediately
apparent from net income (loss) as determined in accordance with GAAP. However,
FFO and NFFO should not be construed to be (i) more relevant or accurate than
the current GAAP methodology in calculating net income (loss) as an indicator of
our operating performance, (ii) more relevant or accurate than GAAP cash flows
from operations as an indicator of our liquidity or (iii) indicative of funds
available to fund our cash needs, including our ability to make distributions to
our stockholders. The method utilized to evaluate the value and performance of
real estate under GAAP should be construed as a more relevant measure of
operational performance and considered more prominently than the non-GAAP FFO
and NFFO measures and the adjustments to GAAP in calculating FFO and NFFO.
Presentation of this information is intended to provide useful information to
investors, industry analysts and management as they compare the operating
performance metrics used by the REIT industry, although it should be noted that
some REITs may use different methods of calculating funds from operations and
normalized funds from operations, so comparisons with such REITs may not be
meaningful.
Net Operating Income (NOI)
We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are
appropriate supplemental performance measures to reflect the performance of our
operating assets because NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI
exclude certain items that are not associated with the operations of the
properties. We believe that NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI
are widely accepted measures of comparative operating performance in the real
estate community and are useful to investors in understanding the profitability
and operating performance of our property portfolio. However, our use of the
terms NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI may not be comparable
to that of other real estate companies as they may have different methodologies
for computing these amounts.
NOI, Cash NOI, Pro-Rata Cash NOI and Same-Store NOI are not equivalent to our
net income (loss) as determined under GAAP and may not be a useful measure of
operational income or cash flows. Furthermore, NOI, Cash NOI, Pro-Rata Cash NOI
and Same-Store NOI should not be considered as alternatives to net income (loss)
as an indication of our operating performance or as an alternative to cash flows
from operations as an indication of our liquidity. NOI, Cash NOI, Pro-Rata Cash
NOI and Same-Store NOI should not be construed to be more relevant or accurate
than the GAAP methodology in calculating net income (loss). NOI, Cash NOI, Pro-
Rata Cash NOI and Same-Store NOI should be reviewed in conjunction with other
measurements as an indication of our performance.
Page |5
About American Healthcare REIT, Inc.
American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust
that acquires, owns and operates a diversified portfolio of clinical healthcare
real estate, focusing primarily on senior housing communities, skilled nursing
facilities, and outpatient medical buildings across the United States, and in
the United Kingdom and the Isle of Man.
Page |6
AMERICAN HEALTHCARE REIT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS As of
September 30, 2026 and December 31, 2025 (In thousands, except share and per
share amounts) (Unaudited)
September 30, December 31,
2026 2025
──────────────────────────────────────────────────────────────────────────────
ASSETS
Real estate investments, net $ 5,949,084 $ 4,183,419
Debt investments, net 240,808 92,136
Cash and cash equivalents 222,767 114,836
Restricted cash 35,905 36,917
Accounts and other receivables, 228,503 204,313
net
Identified intangible assets, 370,206 253,236
net
Goodwill 234,942 234,942
Operating lease right-of-use 149,524 135,399
assets, net
Other assets, net 177,618 171,028
Total assets $ 7,609,357 $ 5,426,226
LIABILITIES, REDEEMABLE
NONCONTROLLING
INTERESTS AND EQUITY
Liabilities:
Mortgage loans payable, net $ 814,957 $ 966,925
Lines of credit and term loan, 549,927 549,761
net
Accounts payable and accrued 372,123 317,742
liabilities
Identified intangible 1,717 2,110
liabilities, net
Financing obligations 19,208 33,902
Operating lease liabilities 135,430 135,603
Security deposits, prepaid rent
and 66,538 59,568
other liabilities
Total liabilities 1,959,900 2,065,611
Commitments and contingencies
Redeemable noncontrolling 66,810 —
interests
Equity:
Stockholders’ equity:
Preferred stock, $0.01 par
value per share; 200,000,000 — —
shares authorized;
none issued and outstanding
Common stock, $0.01 par value
per share; 1,000,000,000 shares
authorized;
231,479,253 and 185,911,442 2,311 1,852
shares issued and outstanding
as of
September 30, 2026 and December
31, 2025, respectively
Additional paid-in capital 7,164,243 4,880,169
Accumulated deficit (1,628,682 ) (1,559,279 )
Accumulated other comprehensive (2,205 ) (2,104 )
loss
Total stockholders’ equity 5,535,667 3,320,638
Noncontrolling interests 46,980 39,977
Total equity 5,582,647 3,360,615
Total liabilities, redeemable
noncontrolling interests and $ 7,609,357 $ 5,426,226
equity
Page |7
AMERICAN HEALTHCARE REIT, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE INCOME For the Three and Nine Months Ended September 30, 2026
and 2025 (In thousands, except share and per share amounts) (Unaudited)
Three Nine
Mont… Mon…
Ended End…
Sept… Sep…
30, 30,
Rev… 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
Res…
fees $ 701,… $ 532,… $ 1,94… $ 1,5…
and
ser…
Real
est… 41,0… 40,8… 121,… 125…
rev…
Tot… 742,… 572,… 2,06… 1,6…
rev…
Exp…
Pro…
ope… 564,… 454,… 1,60… 1,3…
exp…
Ren… 12,6… 12,5… 37,8… 39,…
exp…
Gen…
and 21,5… 14,1… 59,0… 42,…
adm…
Tra…
tra…
and 5,113 50 9,870 1,8…
res…
cos…
Dep…
and 90,8… 49,1… 230,… 132…
amo…
Tot… 694,… 530,… 1,93… 1,5…
exp…
Oth…
inc…
(ex…
Int…
exp…
Int…
exp… (17,… ) (20,… ) (55,… ) (65… )
net
(Lo…
gain
in
fair
val… (106 ) 166 1,778 (1,… )
of
der…
fin…
ins…
Gain
(lo…
on
dis…
of — 691 5,647 (2,… )
real
est…
inv…
net
Imp…
of
real — (3,7… ) (2,1… ) (38… )
est…
inv…
Inc…
(lo…
from 49 462 1,733 (2,… )
unc…
ent…
Gain
on
re-…
of — 14,5… — 14,…
pre…
held
equ…
int…
For…
cur… (619 ) (977 ) (1,3… ) 3,1…
(lo…
gain
Oth…
inc… 3,473 2,309 7,722 5,3…
net
Tot…
net (14,… ) (6,9… ) (41,… ) (87… )
oth…
exp…
Inc…
bef… 32,2… 35,5… 86,7… 40,…
inc…
tax…
Inc…
tax (740 ) 21,0… (212 ) 19,…
(ex…
ben…
Net 31,5… 56,6… 86,5… 59,…
inc…
Net
inc…
att… (302 ) (712 ) (974 ) (847 )
to
non…
int…
Net
inc…
att… $ 31,2… $ 55,9… $ 85,5… $ 59,…
to
con…
int…
Net
inc…
per
com…
sha…
att…
to
con…
int…
Bas… $ 0.14 $ 0.33 $ 0.43 $ 0.36
Dil… $ 0.14 $ 0.33 $ 0.43 $ 0.36
Wei…
ave…
num…
of
com…
sha…
out…
Bas… 216,… 169,… 199,… 162…
Dil… 217,… 169,… 199,… 162…
Net $ 31,5… $ 56,6… $ 86,5… $ 59,…
inc…
Oth…
com…
inc…
(lo…
For…
cur… 8 (121 ) (101 ) 398
tra…
adj…
Tot…
oth…
com… 8 (121 ) (101 ) 398
inc…
(lo…
Com… 31,5… 56,5… 86,4… 60,…
inc…
Com…
inc…
att… (302 ) (712 ) (974 ) (847 )
to
non…
int…
Com…
inc…
att… $ 31,2… $ 55,8… $ 85,4… $ 59,…
to
con…
int…
Page |8
AMERICAN HEALTHCARE REIT, INC. NAREIT FFO and Normalized FFO Reconciliation For
the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands,
except share and per share amounts) (Unaudited)
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Net $ 31,5… $ 56,6… $ 86,5… $ 59,8…
inc…
Dep…
and
amo…
rel…
to 90,8… 49,1… 229,… 131,…
real
est…
—
con…
pro…
Dep…
and
amo…
rel…
to 43 15 71 1,018
real
est…
—
unc…
ent…
Imp…
of
real
est… — 3,768 2,137 38,1…
inv…
—
con…
pro…
(Ga…
loss
on
dis…
of
real — (691 ) (5,6… ) 2,344
est…
inv…
net
—
con…
pro…
Gain
on
re-…
of — (14,… ) — (14,… )
pre…
held
equ…
int…
Net
inc…
att… (302 ) (712 ) (974 ) (847 )
to
non…
int…
Dep…
amo…
imp…
net
gai…
on
dis… (1,4… ) (521 ) (3,0… ) (2,2… )
and
gain
on
re-…
—
non…
int…
NAR…
FFO
att… $ 120,… $ 93,0… $ 308,… $ 215,…
to
con…
int…
Tra…
tra…
and $ 5,113 $ 50 $ 9,870 $ 1,808
res…
cos…
Amo…
of
abo… 281 295 911 1,063
and
bel…
lea…
Amo…
of
dir…
ori…
and 739 11 763 60
clo…
cos…
—
debt
inv…
Cha…
in (184 ) (485 ) (1,1… ) (1,8… )
def…
rent
Non…
imp…
of
cha… 9,284 3,429 19,9… 9,170
to
equ…
ins…
(1)
Non…
inc… (294 ) (21,… ) (1,2… ) (21,… )
tax
ben…
Cap… (834 ) (401 ) (2,1… ) (843 )
int…
(Ga…
loss
on — (22 ) 147 1,784
debt
ext…
Loss
(ga…
in
fair
val… 106 (166 ) (1,7… ) 1,213
of
der…
fin…
ins…
For…
cur… 619 977 1,363 (3,1… )
loss
(ga…
Oth…
non… (8,8… ) — (8,8… ) —
inc…
(2)
Adj…
for (1 ) (1 ) (2 ) 4
unc…
ent…
Adj…
for (62 ) 211 (192 ) 139
non…
int…
Nor…
FFO
att… $ 126,… $ 75,5… $ 326,… $ 203,…
to
con…
int…
NAR…
FFO
and
Nor…
FFO
wei… 217,… 169,… 199,… 162,…
ave…
com…
sha…
out…
—
dil…
NAR…
FFO
per
com…
sha…
att… $ 0.55 $ 0.54 $ 1.55 $ 1.32
to
con…
int…
—
dil…
Nor…
FFO
per
com…
sha…
att… $ 0.58 $ 0.44 $ 1.64 $ 1.25
to
con…
int…
—
dil…
(1) For the three and nine months ended September 30, 2026, stock compensation
expense includes $4,594,000 related to the accelerated vesting and modification
of certain outstanding equity awards in connection with our previously disclosed
Chief Executive Officer and Chief Financial Officer transitions during the third
quarter of 2026, net of forfeitures. (2) Represents certain Ohio Medicaid
quality incentive payments received by our ISHC segment pursuant to Ohio House
Bill 479, or HB 479, that do not relate to the 2026 rate period. HB 479 was
enacted in June 2026 and appropriated funding for nursing facility quality
incentive payments. These amounts are included in resident fees and services
revenue in our accompanying condensed consolidated statements of operations and
comprehensive income, but are not reflective of our on-going operating
performance.
Page |9
AMERICAN HEALTHCARE REIT, INC. Adjusted EBITDA Reconciliation For the Three
Months Ended September 30, 2026 (In thousands) (Unaudited)
Net income $ 31,515
Interest expense, net (including amortization of deferred
financing costs and amortization of debt 17,773
discount/premium)
Income tax expense 740
Depreciation and amortization (including
amortization of leased assets and 91,403
accretion of lease liabilities)
EBITDA 141,431
Income from unconsolidated entities (49 )
Straight line rent and amortization of (437 )
above/below market leases
Non-cash impact of changes to equity 9,284
instruments
Transaction, transition and 5,113
restructuring costs
Amortization of direct origination and 739
closing costs — debt investments
Foreign currency loss 619
Loss in fair value of derivative 106
financial instruments
Other non-recurring income (8,815 )
Adjusted EBITDA $ 147,991
Page |10
AMERICAN HEALTHCARE REIT, INC. NOI and Cash NOI Reconciliation For the Three and
Nine Months Ended September 30, 2026 and 2025 (In thousands) (Unaudited)
Net
inc…
Gen…
and
adm…
Tra…
tra…
and
res…
cos…
Dep…
and
amo…
Int…
exp…
net
Loss
(ga…
in
fair
val…
of
der…
fin…
ins…
(Ga…
loss
on
dis…
of
real
est…
inv…
net
Imp…
of
real
est…
inv…
(In…
loss
from
unc…
ent…
Gain
on
re-…
of
pre…
held
equ…
int…
For…
cur…
loss
(ga…
Oth…
inc…
net
Inc…
tax
exp…
(be…
Net
ope…
inc…
Str…
line 31,5… 56,6… 86,5… 59,…
rent 21,5… 14,1… 59,0… 42,…
Fac… 5,113 50 9,870 1,8…
ren… 90,8… 49,1… 230,… 132…
exp… 17,7… 20,3… 55,1… 65,…
Oth… 106 (166 (1,7… 1,2…
non… — (691 (5,6… 2,3…
adj… — 3,768 2,137 38,…
Cash (49 (462 (1,7… 2,6…
NOI — (14,… — (14…
from 619 977 ) 1,363 (3,…
dis… (3,4… (2,3… ) (7,7… (5,…
Cash 740 (21,… ) 212 ) (19… )
NOI Three 164,… 105,… ) Nine 427,… ) 303… )
att… Mont… (297 ) (730 ) Mon… (1,5… ) (2,… )
to Ended 6,752 ) 7,030 ) End… 20,2… ) 21,… )
non… Sept… 934 ) 133 ) Sep… 1,025 ) 517 )
int… 30, (6 ) (102 ) 30, (351 ) (716 )
(1) 2026 (734 ) 2025 (251 ) 2026 (1,2… ) 2025 (758 )
──────────────────────────────────────────────────────────────────────────────
Cash
NOI $ 171,… $ 111,… $ 445,… $ 322…
(1)
(1) All periods are based upon current quarter's ownership percentage.
Page |11
AMERICAN HEALTHCARE REIT, INC. Same-Store Revenue Reconciliation For the Three
and Nine Months Ended September 30, 2026 and 2025 (In thousands) (Unaudited)
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
30, 30,
ISHC 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
GAAP $ 534,… $ 455… $ 1,5… $ 1,31…
Rev…
Cash
rev… — 1 (2,… ) (2,6… )
from
dis…
Cash 534,… 455… 1,5… 1,31…
rev…
Rev…
att…
to (177… ) (11… ) (50… ) (330… )
new
acq…
Rev…
att…
to (3,5… ) (6,… ) (13… ) (19,… )
Non…
Pro…
Oth…
nor… (7,7… ) — (7,… ) —
rev…
adj…
Sam… $ 345,… $ 329… $ 1,0… $ 961,…
rev…
SHOP
GAAP $ 166,… $ 76,… $ 395… $ 217,…
Rev…
Cash
rev… — (1 ) — (167 )
from
dis…
Cash
rev…
att…
to (1,9… ) (278 ) (2,… ) (824 )
non…
int…
(1)
Cash
rev… 164,… 76,… 393… 216,…
(1)
Rev…
att…
to (88,… ) (6,… ) (16… ) (9,6… )
new
acq…
Rev…
att…
to (1,1… ) (864 ) (3,… ) (2,2… )
dev…
con…
Rev…
att…
to (599 ) (580 ) (1,… ) (1,7… )
Non…
Pro…
Sam…
rev… $ 74,8… $ 68,… $ 218… $ 202,…
(1)
Out…
Med…
GAAP $ 30,6… $ 31,… $ 91,… $ 95,6…
Rev…
Str…
line 24 (243 ) (434 ) (675 )
rent
Oth…
non… (343 ) (380 ) (1,… ) (1,0… )
adj…
Cash
rev… 1 (427 ) — (887 )
from
dis…
Cash 30,3… 30,… 89,… 93,0…
rev…
Rev…
att… — (154 ) — (4,0… )
to
dis…
Rev…
att…
to (1,8… ) (2,… ) (5,… ) (7,1… )
Non…
Pro…
Sam… $ 28,5… $ 27,… $ 84,… $ 81,8…
rev…
Tri…
Lea…
Pro…
GAAP $ 10,3… $ 9,6… $ 30,… $ 29,8…
Rev…
Str…
line (321 ) (487 ) (1,… ) (1,6… )
rent
Oth…
non… 881 200 1,2… 624
adj…
Cash
rev… — (25 ) (27 ) (25 )
from
dis…
Cash
rev…
att…
to (198 ) (194 ) (587 ) (575 )
non…
int…
(1)
Cash
rev… 10,7… 9,1… 29,… 28,3…
(1)
Debt
inv… (2,7… ) (1,… ) (5,… ) (3,8… )
(2)
Rev…
att… — — — (52 )
to
dis…
Rev…
att…
to — (157 ) (159 ) (470 )
Non…
Pro…
Oth…
nor… — — (354 ) (522 )
rev…
adj…
Sam…
rev… $ 7,981 $ 7,8… $ 24,… $ 23,4…
(1)
Page |12
AMERICAN HEALTHCARE REIT, INC. Same-Store Revenue Reconciliation - (Continued)
For the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands)
(Unaudited)
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
Tot… 30, 30,
Por… 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
GAAP $ 742,… $ 572… $ 2,0… $ 1,65…
Rev…
Str…
line (297 ) (730 ) (1,… ) (2,2… )
rent
Oth…
non… 538 (180 ) 27 (430 )
adj…
Cash
rev… 1 (452 ) (2,… ) (3,7… )
from
dis…
Cash
rev…
att…
to (2,1… ) (472 ) (3,… ) (1,3… )
non…
int…
(1)
Cash
rev… 740,… 571… 2,0… 1,64…
(1)
Debt
inv… (2,7… ) (1,… ) (5,… ) (3,8… )
(2)
Rev…
att…
to (265… ) (12… ) (67… ) (343… )
new
acq…
Rev…
att…
to (1,1… ) (864 ) (3,… ) (2,2… )
dev…
con…
Rev…
att…
to (6,0… ) (9,… ) (21… ) (28,… )
Non…
Pro…
Oth…
nor… (7,7… ) — (8,… ) (522 )
rev…
adj…
Sam…
rev… $ 456,… $ 434… $ 1,3… $ 1,26…
(1)
(1) All periods are based upon current quarter's ownership percentage. (2)
Relates to debt security investment and debt investment within Triple-Net Leased
Properties.
Page |13
AMERICAN HEALTHCARE REIT, INC. Same-Store NOI Reconciliation For the Three and
Nine Months Ended September 30, 2026 and 2025 (In thousands) (Unaudited)
Three Nine
Mont… Mont…
Ended Ended
Sept… Sept…
30, 30,
ISHC 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
NOI $ 90,0… $ 62,… $ 239… $ 176,…
Fac…
ren… 6,752 7,0… 20,… 21,8…
exp…
Cash
NOI — 1 (328 ) (472 )
from
dis…
Cash 96,7… 69,… 259… 197,…
NOI
New (16,… ) (6,… ) (38… ) (12,… )
acq…
Non… (510 ) (1,… ) (1,… ) (2,8… )
Pro…
Oth…
nor… (7,7… ) 1,0… (7,… ) 1,044
adj…
Sam… $ 72,4… $ 62,… $ 211… $ 183,…
NOI
SHOP
NOI $ 46,2… $ 15,… $ 103… $ 41,1…
Oth…
non… 102 — 102 —
adj…
Cash
NOI — 24 — 88
from
dis…
Cash
NOI
att…
to (536 ) (58 ) (648 ) (185 )
non…
int…
(1)
Cash
NOI 45,7… 15,… 103… 41,0…
(1)
New (28,… ) (1,… ) (54… ) (2,7… )
acq…
Dev… (104 ) 343 207 980
con…
Non… (24 ) (59 ) (122 ) (176 )
Pro…
Oth…
nor… — — — 147
adj…
Sam…
NOI $ 17,5… $ 13,… $ 48,… $ 39,2…
(1)
Out…
Med…
NOI $ 18,5… $ 19,… $ 55,… $ 58,6…
Str…
line 24 (243 ) (434 ) (675 )
rent
Oth…
non… (68 ) (85 ) (382 ) (162 )
adj…
Cash
NOI (6 ) (127 ) 4 (332 )
from
dis…
Cash 18,5… 18,… 54,… 57,5…
NOI
Dis… — 83 — (1,7… )
Non… (956 ) (1,… ) (2,… ) (4,1… )
Pro…
Sam… $ 17,5… $ 17,… $ 52,… $ 51,5…
NOI
Tri…
Lea…
Pro…
NOI $ 9,966 $ 9,1… $ 28,… $ 27,6…
Str…
line (321 ) (487 ) (1,… ) (1,6… )
rent
Oth…
non… 900 218 1,3… 679
adj…
Cash
NOI — — (27 ) —
from
dis…
Cash
NOI
att…
to (198 ) (193 ) (586 ) (573 )
non…
int…
(1)
Cash
NOI 10,3… 8,6… 27,… 26,0…
(1)
Debt
inv… (2,7… ) (1,… ) (5,… ) (3,8… )
(2)
Dis… — — — 3
Non… — (157 ) (159 ) (464 )
Pro…
Sam…
NOI $ 7,576 $ 7,3… $ 22,… $ 21,8…
(1)
Page |14
AMERICAN HEALTHCARE REIT, INC. Same-Store NOI Reconciliation - (Continued) For
the Three and Nine Months Ended September 30, 2026 and 2025 (In thousands)
(Unaudited)
Three Nine
Mont… Mon…
Ended End…
Sept… Sep…
Tot… 30, 30,
Por… 2026 2025 2026 2025
──────────────────────────────────────────────────────────────────────────────
NOI $ 164,… $ 105,… $ 427,… $ 303…
Str…
line (297 ) (730 ) (1,5… ) (2,… )
rent
Fac…
ren… 6,752 7,030 20,2… 21,…
exp…
Oth…
non… 934 133 1,025 517
adj…
Cash
NOI (6 ) (102 ) (351 ) (716 )
from
dis…
Cash
NOI
att…
to (734 ) (251 ) (1,2… ) (758 )
non…
int…
(1)
Cash
NOI 171,… 111,… 445,… 322…
(1)
Debt
inv… (2,7… ) (1,1… ) (5,1… ) (3,… )
(2)
New (44,… ) (8,3… ) (93,… ) (16… )
acq…
Dev… (104 ) 343 207 980
con…
Non… (1,4… ) (2,5… ) (4,9… ) (7,… )
Pro…
Oth…
nor… (7,7… ) 1,044 (7,7… ) 1,1…
adj…
Sam…
NOI $ 115,… $ 101,… $ 334,… $ 295…
(1)
(1) All periods are based upon current quarter's ownership percentage. (2)
Relates to debt security investment and debt investment within Triple-Net Leased
Properties.
Page |15
AMERICAN HEALTHCARE REIT, INC. Earnings Guidance Reconciliation For the Year
Ending December 31, 2026 (Dollars and shares in millions, except per share
amounts) (Unaudited)
Full Year Prior Full Year
2026 Guidance 2026 Guidance
Low High Low High
Net income
attributable to $123.2 $129.2 $108.5 $116.5
common
stockholders
Depreciation and 322.1 322.1 306.8 306.8
amortization (1)
Impairment and
gains/losses from -3.5 -3.5 -3.9 -3.9
dispositions (1)
NAREIT FFO
attributable to $441.8 $447.8 $411.4 $419.4
common
stockholders
Amortization of
other intangible 2.7 2.7 1.3 1.3
assets/liabilities
(1)
Change in deferred -1.3 -1.3 -1.6 -1.6
rent (1)
Non-cash impact of
changes to equity 26.3 26.3 21.9 21.9
plan (1) (2)
Other adjustments -6.2 -6.2 -0.2 -0.2
(1) (3)
Normalized FFO
attributable to $463.3 $469.3 $432.8 $440.8
common
stockholders
Net income per
common share — $0.59 $0.62 $0.54 $0.58
diluted
NAREIT FFO per
common share — $2.13 $2.16 $2.04 $2.08
diluted
Normalized FFO per
common share — $2.23 $2.26 $2.15 $2.19
diluted
NAREIT FFO and
Normalized FFO 207.7 207.7 201.3 201.3
weighted average
shares — diluted
Total Portfolio
Same-Store NOI 12.0% 14.0% 11.0% 13.0%
growth
Segment-Level
Same-Store NOI
growth:
ISHC 14.5% 16.5% 13.0% 16.0%
SHOP 23.0% 26.0% 18.0% 21.0%
Outpatient Medical 0.5% 1.0% 0.0% 1.0%
Triple-Net Leased 2.5% 3.5% 2.0% 3.0%
Properties
(1) Amounts presented net of noncontrolling interests' share and AHR's share of
unconsolidated entities. (2) Amounts represent amortization of equity
compensation and fair value adjustments to performance-based equity
compensation. (3) Includes adjustments for capitalized interest, transaction,
transition and restructuring costs, and additional items as noted in the
Company’s definition of Normalized FFO.
Page |16
Definitions
Adjusted EBITDA: EBITDA excluding the impact of income or loss from
unconsolidated entities, straight line rent and amortization of above/below
market leases, non-cash impact of changes to equity instruments, transaction,
transition and restructuring costs, gain or loss on dispositions of real estate
investments, amortization of direct origination and closing costs on debt
investments, unrealized foreign currency gain or loss, change in fair value of
derivative financial instruments, impairments of real estate investments,
impairments of intangible assets and goodwill, and non-recurring and/or one-time
items.
Annualized Adjusted EBITDA: Current period (shown as quarterly) Adjusted EBITDA
multiplied by 4.
ATM Program: At-the-market equity offering program.
Cash NOI: NOI excluding the impact of, without duplication, (1) non-cash items
such as straight-line rent and the amortization of lease intangibles, (2) third-
party facility rent payments and (3) other items set forth in the Cash NOI
reconciliation included herein. Both Cash NOI and Same-Store NOI include Pro-
Rata ownership and other adjustments.
EBITDA: A non-GAAP financial measure that is defined as earnings before
interest, taxes, depreciation and amortization.
GAAP Revenue: Revenue recognized in accordance with Generally Accepted
Accounting Principles (“GAAP”), which includes straight line rent and other non-
cash adjustments.
ISHC: Integrated senior health campuses include a range of senior care,
including independent living, assisted living, memory care, skilled nursing
services and certain ancillary businesses. Integrated senior health campuses are
operated utilizing a RIDEA structure.
NAREIT FFO or FFO: Funds from operations attributable to controlling interest; a
non-GAAP financial measure, consistent with the standards established by the
White Paper on FFO approved by the Board of Governors of NAREIT (the “White
Paper”). The White Paper defines FFO as net income (loss) computed in accordance
with GAAP, excluding gains or losses from dispositions of certain real estate
assets, gains or losses upon consolidation of a previously held equity interest,
and impairment write-downs of certain real estate assets and investments, plus
depreciation and amortization related to real estate, after adjustments for
unconsolidated partnerships and joint ventures. While impairment charges are
excluded from the calculation of FFO as described above, investors are cautioned
that impairments are based on estimated future undiscounted cash flows.
Adjustments for unconsolidated partnerships and joint ventures are calculated to
reflect FFO.
Net Debt: Total Debt, excluding operating lease liabilities, less cash and cash
equivalents and restricted cash related to debt. For a reconciliation of Net
Debt to total debt, refer to the Company’s Third Quarter 2026 Supplemental
Financial Information.
NOI: Net operating income; a non-GAAP financial measure that is defined as net
income (loss), computed in accordance with GAAP, generated from properties
before general and administrative expenses, transaction, transition and
restructuring costs, depreciation and amortization, interest expense, gain or
loss in fair value of derivative financial instruments, gain or loss on
dispositions of real estate investments, impairment of real estate investments,
impairment of intangible assets and goodwill, income or loss from unconsolidated
entities, gain on re-measurement of previously held equity interest, foreign
currency gain or loss, other income or expense and income tax benefit or
expense.
Non-Core Properties: Assets that have been deemed not essential to generating
future economic benefit or value to our day-to-day operations and/or are
projected to be sold.
Normalized FFO or NFFO: FFO further adjusted for the following items included in
the determination of GAAP net income (loss): transaction, transition and
restructuring costs; amounts relating to changes in deferred rent and
amortization of above- and below-market leases (which are adjusted in order to
reflect such payments from a GAAP accrual basis); the non-cash impact of changes
to our equity instruments; non-cash or non-recurring income or expense; the non-
cash effect of income tax benefits or expenses; capitalized interest; impairment
of intangible assets and goodwill; amortization of direct origination and
closing costs on debt investments; mark-to-market adjustments included in net
income (loss); gains or losses included in net income (loss) from the
extinguishment or sale of debt, hedges, foreign exchange, derivatives or
securities holdings where trading of such holdings is not a fundamental
attribute of the business plan; and after adjustments for consolidated and
unconsolidated partnerships and joint ventures, with such adjustments calculated
to reflect Normalized FFO on the same basis.
Occupancy: With respect to OM, the percentage of total rentable square feet
leased and occupied, including month-to-month leases, as of the date reported.
With respect to all other property types, occupancy represents average quarterly
operating occupancy based on the most recent quarter of available data. The
Company uses unaudited, periodic financial information provided solely by
tenants to calculate occupancy and has not independently verified the
information.
Outpatient Medical or OM: Outpatient Medical properties.
Pro-Rata: As of September 30, 2026, we owned and/or operated
buildings/properties through entities of which we owned less than 100% of the
ownership interests. Because we have a controlling interest in these entities,
these entities and the properties these entities own are consolidated in our
financial statements in accordance with GAAP. However, while such properties are
presented in our financial statements on a consolidated basis, we are only
entitled to our Pro-Rata share of the net cash flows generated by such
properties. As a result, we have presented certain property information herein
based on our Pro-Rata ownership interest in these entities and the properties
these entities own, as of the applicable date, and not on a consolidated basis.
In such instances, information is noted as being presented on a “Pro-Rata share”
basis.
Page |17
RIDEA structure: A structure permitted by the REIT Investment Diversification
and Empowerment Act of 2007, pursuant to which we lease certain healthcare real
estate properties to a wholly-owned taxable REIT subsidiary (“TRS”), which in
turn contracts with an eligible independent contractor (“EIK”) to operate such
properties for a fee. Under this structure, the EIK receives management fees,
and the TRS receives revenue from the operation of the healthcare real estate
properties and retains, as profit, any revenue remaining after payment of
expenses (including intercompany rent paid to us and any taxes at the TRS level)
necessary to operate the property. Through the RIDEA structure, in addition to
receiving rental revenue from the TRS, we retain any after-tax profit from the
operation of the healthcare real estate properties and benefit from any improved
operational performance while bearing the risk of any decline in operating
performance at the properties.
Same-Store or SS: Properties owned or consolidated the full year in both
comparison years and that are not otherwise excluded. Properties are excluded
from Same-Store if they are: (1) sold, classified as held for sale or properties
whose operations were classified as discontinued operations in accordance with
GAAP; (2) impacted by materially disruptive events, such as flood or fire for an
extensive period of time; or (3) scheduled to undergo or currently undergoing
major expansions/renovations or business model transitions or have transitioned
business models after the start of the prior comparison period.
Same-Store NOI or SS NOI: Cash NOI for our Same-Store properties. Same-Store NOI
is used to evaluate the operating performance of our properties using a
consistent population which controls for changes in the composition of our
portfolio. Both Cash NOI and Same-Store NOI include ownership and other
adjustments.
SHOP: Senior housing operating properties.
Total Debt: The principal balances of the Company’s revolving credit facilities,
term loan and secured indebtedness as reported in the Company’s consolidated
financial statements.
Trilogy: Trilogy Investors, LLC; one of our consolidated subsidiaries, in which
we indirectly own a 100% interest as of September 30, 2026.
Trilogy Management Services: Trilogy Management Services, LLC, an independent
third-party operator that qualifies as an eligible independent contractor and
manages all of the Company's integrated senior health campuses.
Triple-Net Leased: A lease where the tenant is responsible for making rent
payments, maintaining the leased property, and paying property taxes and other
expenses.
Page |18